Neuroendocrine tumours: Clinical presentation and management of localized disease

Cancer Treatment Reviews

Volumn 29, Issue 5, 2003, Pages 363-370

  Kulke, Matthew H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carcinoid; Islet cell tumour; Local disease; Neuroendocrine tumour; Pancreatic endocrine tumour

Indexed keywords

AMINO ACID; BIOGENIC AMINE; DIAZOXIDE; GLUCOSE; HORMONE; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE;

APPENDIX TUMOR; BRONCHUS CARCINOID; CANCER SURGERY; CANCER THERAPY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET THERAPY; DISEASE ASSOCIATION; ENUCLEATION; GASTRINOMA; GLUCAGONOMA; HORMONE RELEASE; HUMAN; INSULINOMA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; RECTUM TUMOR; REVIEW; SMALL INTESTINE TUMOR; SOMATOSTATINOMA; STOMACH ANTRUM RESECTION; STOMACH TUMOR; SYMPTOMATOLOGY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; VIPOMA;

EID: 0141502365     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(03)00072-0     Document Type: Article

References (96)

1. Godwin J. Carcinoid tumours: an analysis of 2837 cases. Cancer 1975; 36: 560-569.
2. Modlin I, Sandor A. An analysis of 8305 cases of carcinoid tumours. Cancer 1997; 79: 813-829.
3. Thorson A, et al. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease on the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis. Am Heart J 1954; 47: 795-817.
4. Harpole D, et al. Bronchial carcinoid tumours: a retrospective analysis of 126 patients. Ann Thorac Surg 1992; 54: 50-55.
5. Vadasz P, et al. Diagnosis and treatment of bronchial carcinoid tumours: clinical and pathological review of 120 operated patients. Eur J Cardiothorac Surg 1993; 7: 8-11.
6. Warren W, et al. Neuroendocrine neoplasms of the bronchopulmonary tract: a classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 1985; 89: 819-825.
7. Torre M, et al. Typical and atypical bronchial carcinoids. Resp Med 1989; 83: 305-308.
8. Okike N, Bernatz P, Woolner L. Carcinoid tumours of the lung. Ann Thorac Surg 1976; 22: 270-277.
9. Limper A, et al. The Cushing syndrome induced by bronchial carcinoid tumours. Ann Intern Med 1992; 117: 209-214.
10. Rea F, et al. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989; 47: 412-414.
11. McCaughan B, Martini N, Bains M. Bronchial carcinoids: review of 124 cases. J Thorac Cardiovasc Surg 1985; 89: 8-17.
12. Chughtai T, et al. Bronchial carcinoid-twenty years' experience defines a selective surgical approach. Surgery 1997; 122: 801-808.
13. Dusmet M, McKneally M. Pulmonary and thymic carcinoid tumours. World J Surg 1996; 20: 189-195.
14. Schreurs A, et al. A twenty five year follow up of ninety-three resected typical carcinoid tumours of the lung. J Thorac Cardiovasc Surg 1992; 104: 1470-1475.
15. Smolle-Juttner F, et al. Clinical features and therapy of "typical" and "atypical" bronchial carcinoid tumours (grade 1 and grade 2 neuroendocrine carcinoma). Eur J Cardiothorac Surg 1993; 7: 121-125.
16. Marty-Ane C, et al. Carcinoid tumours of the lung: do atypical features require aggressive management. Ann Thorac Surg 1995; 59: 78-83.
17. Modlin I, et al. Gastric carcinoids: the Yale experience. Arch Surg 1995; 130: 250-256.
18. Rindi G, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996; 20: 168-172.
19. Bordi C, et al. Gastric carcinoids and their precursor lesions. Cancer 1991; 67: 663-672.
20. Thomas R, et al. Gastric carcinoids: an immunohistochemical and clinicopathologic study of 104 patients. Cancer 1994; 73: 2053-2058.
21. Gough D, et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994; 18: 473-479.
22. Sjoblom S, et al. Mucosal argyrophil endocrine cells in pernicious anemia and upper gastrointestinal carcinoid tumours. J Clin Pathol 1994; 42: 371-377.
23. Solcia E, et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1991; 26(Suppl 180): 146-159.
24. Rindi G, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: achnicopathologic study. Gastroenterology 1993; 104: 994-1006.
25. Ahlman H, et al. Clinical management of gastric carcinoid tumours. Digestion 1994; 55(Suppl 3): 77-85.
26. Borch K, et al. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. Am J Surg Pathol 1987; 11: 435-444.
27. Eckhauser F, et al. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery 1988; 104: 1046-1053.
28. Hirschowitz; BI, et al. Rapid regression ofenterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102: 1409-1418.
29. Tomassetti P, et al. Treatment of type II gastric carcinoid tumours with somatostatin analogs. N Engl J Med 2000; 343: 551-554.
30. Barclay T, Schapira D. Malignant tumours of the small intestine. Cancer 1983; 51: 878-881.
31. Moertel C, et al. Life history of the carcinoid tumour of the small intestine. Cancer 1961; 14: 901-912.
32. Makridis C, et al. Surgical treatment of mid-gut carcinoid tumours. World J Surg 1990; 14: 377-385.
33. Burke A, et al. Carcinoids of the jejunum and ileum. Cancer 1997; 79: 1086-1093.
34. Akerstrom G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumours. Acta Oncol 1991; 30: 547-553.
35. Eckhauser F, et al. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 1981; 90: 720-728.
36. Moertel C, Dockerty M, Judd E. Carcinoid tumours of the vermiform appendix. Cancer 1968; 21: 270-278.
37. Roggo A, Wood W, Ottinger L. Carcinoid tumours of the appendix. Ann Surg 1993; 217: 385-390.
38. Anderson J, Wilson B. Carcinoid tumours of the appendix. Br J Surg 1985; 72: 545-546.
39. Thirlby R, Casper C, Jones R. Metastatic carcinoid tumour of the appendix. Dis Colon Rectum 1984; 27: 42-46.
40. MacGillivray D, et al. Distant metastases from a carcinoid tumour of the appendix less than one centimeter in size. Surgery 1992; 111: 466-471.
41. Bowman G, Rosenthal D. Carcinoid tumours of the appendix. Am J Surg 1983; 146: 700-703.
42. Syracuse D, et al. Carcinoid tumours of the appendix: mesoappendiceal extension and nodal metastases. Ann Surg 1979; 190: 58-63.
43. Pearlman D, Srinivasan K. Malignant carcinoid of the appendix. NY State J Med 1971; 71: 1529-1531.
44. Moertel C, et al. Carcinoid tumours of the appendix: treatment and prognosis. N Engl J Med 1987; 317: 1699-1701.
45. Jetmore A, et al. Rectal carcinoids: the most frequent carcinoid tumour. Dis Colon Rectum 1992; 35: 717-725.
46. Soga J. Carcinoids of the rectum: tumours of the carcinoid family-urgut endocrinomas. Acta Medica et Biologica 1982; 29: 157-201.
47. Naunheim K, et al. Rectal carcinoid tumours-treatment and prognosis. Surgery 1983; 94: 670-676.
48. Sauven P, et al. Anorectal carcinoid tumours: is aggressive surgery warranted. Ann Surg 1990; 211: 67-71.
49. Burke M, Shepherd N, Mann C. Carcinoid tumours of the rectum and anus. Br J Surg 1987; 74: 358-361.
50. Koura A, et al. Carcinoid tumours of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer 1997; 79: 1294-1298.
51. Oberg K, Eriksson B. Medical treatment of neuroendocrine gut and pancreatic tumours. Acta Oncol 1989; 28: 425-431.
52. Service FJ, et al. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66(7): 711-719.
53. Grant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin Gastroenterol 1996; 10(4): 645-671.
54. Whipple AO, Franz VK. Adenoma of islet cells with hyperinsulinism. Am Surg 1935; 101: 1299-1335.
55. Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332(17): 1144-1152.
56. Goode PN, et al. Diazoxide in the management of patients with insulinoma. World J Surg 1986; 10(4): 586-592.
57. Grant CS, et al. Insulinoma. The value of intraoperative ultrasonography. Arch Surg 1988; 123(7): 843-848.
58. Pasieka JL, et al. Surgical approach to insulinomas. Assessing the need for preoperative localization. Arch Surg 1992; 127(4): 442-447.
59. Anderson M, et al. Endoscopic ultrasound is highly accurate and directs managment in patients with neuroendocrine tumours of the pancreas. Am J Gastroenterol 2000;95:2271-2277.
60. Menegaux F, et al. Pancreatic insulinomas. Am J Surg 1993; 165(2): 243-248.
61. Rosch T, et al. Localization of pancreatic endocrine tumours by endoscopic ultrasonography. N Engl J Med 1992; 326(26): 1721-1726.
62. O'Riordain DS, et al. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg 1994; 18(4): 488-493, discussion 493-4.
63. Demeure MJ, et al. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery 1991; 110(6): 998-1004, discussion 1004-5.
64. Frankton S, Bloom SR. Gastrointestinal endocrine tumours. Glucagonomas. Baillieres Clin Gastroenterol 1996; 10(4): 697-705.
65. Wermers RA, et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75(2): 53-63.
66. Horrobin DF, Cunnane SC. Interactions between zinc, essential fatty acids and prostaglandins: relevance to acrodermatitis enteropathica, total parenteral nutrition, the glucagonoma syndrome, diabetes, anorexia nervosa and sickle cell anaemia. Med Hypotheses 1980; 6(3): 277-296.
67. Roth E, et al. Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome. Metabolism 1987; 36(1): 7-13.
68. Boden G. Insulinoma and glucagonoma. Semin Oncol 1987; 14(3): 253-262.
69. El Rassi Z, et al. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases. Eur J Surg Oncol 1998; 24(6): 562-567.
70. Jockenhovel F, et al. The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumour growth. Clin Investig 1994; 72(2): 127-133.
71. Edney JA, et al. Glucagonoma syndrome is anunderdiagnosed clinical entity. Am J Surg 1990; 160(6): 625-628, discussion 628-9.
72. Verner JV, Morrison AB. Islet cell tumour and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958; 25: 374-380.
73. Kane MG, O'Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med 1983; 309(24): 1482-1485.
74. Said SI, Faloona GR. Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumours. N Engl J Med 1975; 293(4): 155-160.
75. Long RG, Bryant MG, et al. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (VIPomas). Br Med J 1981; 282: 1767-1771.
76. Kraenzlin ME, et al. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985; 880(1 Pt 1): 185-187.
77. Debas HT, Mulvihill SJ. Neuroendocrine gut neoplasms. Important lessons from uncommon tumours. Arch Surg 1994; 129(9): 965-971, discussion 971-2.
78. Rothmund M, Stinner B, Arnold R. Endocrine pancreatic carcinoma. Eur J Surg Oncol 1991; 17(2): 191-199.
79. Park SK, O'Dorisio MS, O'Dorisio TM. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy. Baillieres Clin Gastroenterol 1996; 10(4): 673-696.
80. Zollinger RM, Ellisou EH. Primary peptic ulcerations of the jejunun associates with islet cell tumours of pancrea. Ann Surg 1955; 142: 709-728.
81. Roy PK, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 2000; 79(6): 379-411.
82. Norton JA, Jensen RT. Unresolved surgical issues in the management of patients with Zollinger Ellison syndrome. World J Surg 1991; 15(1): 151-159.
83. Sugg SL, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993; 218(2): 138-144.
84. Jensen RT. Should the 1996 citation for Zollinger-Ellison syndrome read: "Acid-reducing surgery in, aggressive resection out?". Am J Gastroenterol 1996; 91(6): 1067-1070.
85. Wolfe MM, Jensen RT. Zollinger-Ellison syndrome. Current concepts in diagnosis and management. N Engl J Med 1987; 317(19): 1200-1209.
86. Frucht H, et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med 1989; 111(9): 713-722.
87. Lambers CB, et al. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med 1984; 310(12): 758-761.
88. Frucht H, Maton PN, Jensen RT. Use of omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci 1991; 36(4): 394-404.
89. Stabile BE, Morrow DJ, Passaro Jr E. The gastrinoma triangle: operative implications. Am J Surg 1984; 147(1): 25-31.
90. Fraker DL, et al. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994; 220(3): 320-328, discussion 328-30.
91. de Kerviler E, et al. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. Eur J Nucl Med 1994; 21(11): 1191-1197.
92. Sheppard BC, et al. Management of islet cell tumours in patients with multiple endocrine neoplasia: a prospective study. Surgery 1989; 106(6): 1108-1117, discussion 1117-8.
93. Cheslyn-Curtis S, Sitaram V, Williamson R. Management of non-functioning neuroendocrine tumours of the pancreas. Br J Surg 1993; 80: 625-627.
94. Matthews BD, et al. Surgical experience with non-functioning neuroendocrine tumours of the pancreas. Am Surg 2000; 66(12): 1116-1122.
95. Paladugu R, et al. Bronchopulmonary Kulchitzky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 1985; 55: 1303-1311.
96. Attar S, et al. Bronchial adenoma: a review of 51 patients. Ann Thorac Surg 1985; 40(2): 126-132.